EPCORITAMAB for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where EPCORITAMAB was used for Covid-19.
Most Reported Side Effects for EPCORITAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 551 | 27.0% | 66 | 507 |
| Pyrexia | 258 | 12.6% | 51 | 234 |
| Off label use | 229 | 11.2% | 69 | 182 |
| Febrile neutropenia | 219 | 10.7% | 19 | 216 |
| Pneumonia | 154 | 7.6% | 38 | 138 |
| Covid-19 | 125 | 6.1% | 25 | 108 |
| Sepsis | 106 | 5.2% | 46 | 95 |
| Hypotension | 95 | 4.7% | 31 | 86 |
| Diffuse large b-cell lymphoma | 86 | 4.2% | 46 | 15 |
| Neutropenia | 84 | 4.1% | 24 | 66 |
| Diarrhoea | 83 | 4.1% | 9 | 78 |
| Disease progression | 79 | 3.9% | 42 | 36 |
| Immune effector cell-associated neurotoxicity syndrome | 78 | 3.8% | 34 | 47 |
| C-reactive protein increased | 75 | 3.7% | 2 | 74 |
| Thrombocytopenia | 68 | 3.3% | 24 | 57 |
Other Indications for EPCORITAMAB
Diffuse large b-cell lymphoma (624)
Follicular lymphoma (319)
Diffuse large b-cell lymphoma stage iv (311)
Product used for unknown indication (189)
Diffuse large b-cell lymphoma stage iii (143)
Follicular lymphoma stage iv (110)
Diffuse large b-cell lymphoma stage ii (71)
B-cell lymphoma (63)
Diffuse large b-cell lymphoma stage i (59)
Richter's syndrome (51)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)